等待開盤 11-26 09:30:00 美东时间
+0.800
+2.09%
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 10:22
JP Morgan analyst Richard Shane maintains Enact Holdings (NASDAQ:ACT) with a Neutral and lowers the price target from $40 to $39.
11-08 04:18
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
The latest announcement is out from SynAct Pharma AB ( ($SE:SYNACT) ). SynAct P...
10-30 16:21
北京2025年10月30日 /美通社/ -- 康菲石油中国有限公司("康菲中国")总裁胡凯诚(Markel Hübinette)先生荣获2025年度中国政府友谊...
10-30 11:12
鉴于几乎一半的美国公司市盈率(P/E)高于19倍,甚至超过34倍也不罕见,Enact Holdings, Inc.(纳斯达克代码:ACT)目前7.7倍的市盈率可...
10-29 20:28
Inclusion in Samsung Asset Management's actively managed quantum computing ETF increases BTQ's visibility with Asia-based institutional and thematic investors VANCOUVER, BC, Oct. 28, 2025 /P...
10-28 19:30